Use of corticosteroid therapy in autoimmune hepatitis resulting in the resolution of cirrhosis

Journal of Clinical Gastroenterology

Volumn 32, Issue 5, 2001, Pages 371-372

  Wanless, I R ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

AUTOIMMUNE HEPATITIS; DISEASE COURSE; EDITORIAL; HISTOLOGY; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; PATHOGENESIS; PRIORITY JOURNAL;

ANTI-INFLAMMATORY AGENTS; HEPATITIS, AUTOIMMUNE; HUMANS; LIVER CIRRHOSIS; PREDNISONE;

EID: 0035040930     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200105000-00001     Document Type: Editorial

References (23)

1. Resolution of cirrhosis in autoimmune hepatitis with corticosteroid therapy
2. Ligation of the common bile duct
3. Carbon tetrachloride cirrhosis in relation to liver regeneration
4. Histogenesis and repair of the hepatic cirrhosis in rats produced on low protein diets and preventable with choline
5. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis
6. Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors
7. Tissue inhibitors of metalloproteinases, hepatic stellate cells and liver fibrosis
8. Douze ans de recul dans le traitement de l'hemochromatose par saignees repetees
9. The reversal of hemochromatotic cirrhosis by multiple phlebotomies. Report of a case
10. Penicillamine-induced normalization of clinical signs, and liver morphology and histochemistry in a case of Wilson's disease
11. Colchicine in the treatment of cirrhosis of the liver
12. Regeneration of liver after biliary cirrhosis
13. Hepatic collagen proline hydroxylase activity in hepatic disease following jejunoileal bypass for morbid obesity
14. Reversibility of hepatic fibrosis in autoimmune hepatitis
15. Sustained biochemical and histologic remission of primary biliary cirrhosis in response to medical treatment
16. 10-Year follow-up after interferon-alpha therapy for chronic hepatitis C
17. Regression of hepatic fibrosis in hepatitis C with long-term interferon treatment
18. Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: A dynamic view
19. Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B
20. Physioanatomic considerations
21. Regression of human cirrhosis: Morphologic features and the genesis of incomplete septal cirrhosis
22. Idiopathic portal hypertension: Histologic evidence that some cases may be regressed cirrhosis with portal vein thrombosis
23. Regression of human cirrhosis: In reply